NDT Pharmaceuticals Overview
- Year Founded
-
2005
- Status
-
Public
- Stock Symbol
-
NDTP
- Investments
-
3
- Share Price
-
$0.05
- (As of Thursday Closing)
NDT Pharmaceuticals General Information
Description
NDT Pharmaceuticals Inc is a biotechnology company focused on developing revolutionary therapies for severe neurological disorders associated with traumatic brain injury. Its Nanoscale Particle Complex (NPC) technology represents the phospholipid-based nano-encapsulation delivery systems (less than 100 nanometers in diameter; mean diameter of 40 nanometers in current liquid product samples with the capability to engineer significantly smaller nanocarrier particles) that create instant delivery of payloads into the bloodstream, beginning through the membranes of the mouth. The company is focused on developing products utilizing Intellectual Property.
Contact Information
Website
www.ndtpharma.comCorporate Office
- 8400 Old Courthouse Road
- Vienna, VA 22182
- United States
Corporate Office
- 8400 Old Courthouse Road
- Vienna, VA 22182
- United States
NDT Pharmaceuticals Stock Performance
As of 10-Jul-2025, NDT Pharmaceuticals’s stock price is $0.05. Its current market cap is $8.32M with 160M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.05 | $0.05 | $0.03 - $0.30 | $8.32M | 160M | 2.99K |
NDT Pharmaceuticals Financials Summary
As of 30-Jun-2008, NDT Pharmaceuticals has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2008 | FY 2007 31-Dec-2007 | FY 2006 31-Dec-2006 | FY 2005 31-Dec-2005 |
|---|---|---|---|---|
| EV | 42,932 | |||
| Revenue | 0 | |||
| EBITDA | (212) | |||
| Net Income | (1,229) | (1,037) | (52) | (6) |
| Total Assets | 0 | 109 | 78 | 9 |
| Total Debt | 158 | 101 |
NDT Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
NDT Pharmaceuticals Investments & Acquisitions (3)
NDT Pharmaceuticals’s most recent deal was a Seed Round with Axle (Automation/Workflow Software) for . The deal was made on 21-Jun-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Axle (Automation/Workflow Software) | 21-Jun-2024 | Seed Round | Automation/Workflow Software | ||
| Wisk | 08-Jun-2018 | Seed Round | Business/Productivity Software | ||
| Nature's Bioceuticals | 20-Oct-2011 | Reverse Merger | Food Products |
NDT Pharmaceuticals FAQs
-
When was NDT Pharmaceuticals founded?
NDT Pharmaceuticals was founded in 2005.
-
Where is NDT Pharmaceuticals headquartered?
NDT Pharmaceuticals is headquartered in Vienna, VA.
-
What industry is NDT Pharmaceuticals in?
NDT Pharmaceuticals’s primary industry is Biotechnology.
-
Is NDT Pharmaceuticals a private or public company?
NDT Pharmaceuticals is a Public company.
-
What is NDT Pharmaceuticals’s stock symbol?
The ticker symbol for NDT Pharmaceuticals is NDTP.
-
What is the current stock price of NDT Pharmaceuticals?
As of 10-Jul-2025 the stock price of NDT Pharmaceuticals is $0.05.
-
What is the current market cap of NDT Pharmaceuticals?
The current market capitalization of NDT Pharmaceuticals is $8.32M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
